Sort
23,748 grants matching “melanoma”
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
$164,160Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2018 · CA
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
$164,160Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2019 · CA
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
$164,160Sungjune Kim · H. Lee Moffitt Cancer Ctr & Res Inst · K08 · FY2016 · CA
Structural and functional studies of the human RIO kinases
$164,160Nicole A Laronde · Univ Of Maryland, College Park · K22 · FY2008 · CA
CANCER AND LEUKEMIA GROUP B
$164,155Duke University · U10 · FY2000 · CA
Diagnosis of Cancer with High-Resolution Ultrasound
$164,107Geospace Research, Inc. · R43 · FY2004 · CA
HISTONE LYSINE METHYLTRANSFERASES-CONFORMATIONAL DYNAMICS AND SELECTIVE INHIBITOR DESIGN FOR CHROMATIN-MODIFYING ENZYMES IN LYMPHOMAS AND MELANOMAS
$164,086Weill Medical College Of Cornell University · · FY2017 · Department of the Army
Synergistic innate immune activation and cell killing by RIG-I ligands in HCV-HCC
$164,071Lee Gehrke · Massachusetts Institute Of Technology · R21 · FY2013 · CA
Oral Cancer Screening via Spectral Cytopathology
$164,034Max Diem · Northeastern University · R21 · FY2011 · CA
Oral nanoformulation for the treatment of BRAF inhibitor resistant melanoma
$164,000Ketankumar D. Patel · St. John'S University · SC2 · FY2021 · GM
Keratin proteins and non-melanoma skin tumors
$164,000Pierre Coulombe · Johns Hopkins University · R21 · FY2008 · CA
Oral nanoformulation for the treatment of BRAF inhibitor resistant melanoma
$164,000Ketankumar D. Patel · St. John'S University · SC2 · FY2020 · GM
An Engineered CRISPR System for Boosting Tumor Immunogenicity.
$164,000Weixin Tang · University Of Chicago · R21 · FY2023 · EB
Validation of EP400 downstream effectors and potential therapeutic targets in Merkel cell carcinoma
$163,938Jingwei Cheng · Dana-Farber Cancer Inst · R50 · FY2020 · CA
Validation of EP400 downstream effectors and potential therapeutic targets in Merkel cell carcinoma
$163,938Jingwei Cheng · Dana-Farber Cancer Inst · R50 · FY2019 · CA
Defining an immunological mechanism for a microbiota-based therapy for colorectal cancer
$163,828Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · CA
University of New Mexico Cancer Center Support Grant
$163,814Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2016 · CA
Development of an electrical diagnostic for melanoma
$163,787Richard Lee Nuccitelli · Bioelectromed Corporation · R43 · FY2006 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$163,750Jonathan P Schneck · Johns Hopkins University · R33 · FY2020 · CA
Genome-wide Sequencing to Identify the Genes Responsible for Enchondromatoses and Related Malignant Tumors
$163,750Nara Sobreira · Johns Hopkins University · R03 · FY2022 · CA
Genome-wide Sequencing to Identify the Genes Responsible for Enchondromatoses and Related Malignant Tumors
$163,750Nara Sobreira · Johns Hopkins University · R03 · FY2021 · CA
Dissecting the Role of Germline Genetics in RAS-Driven Cancers
$163,728Ryan Lewis Collins · Dana-Farber Cancer Inst · K99 · FY2024 · CA
Dissecting the Role of Germline Genetics in RAS-Driven Cancers
$163,728Ryan Lewis Collins · Dana-Farber Cancer Inst · K99 · FY2025 · CA
Inhibiting glioma dispersal using non-toxic, natural products
$163,669John S Kuo · University Of Wisconsin-Madison · R21 · FY2012 · CA
Metabolic Engineering of Cancer for Selective Immunotargeting (NIH/NCI: 5R01CA095142-14)
$163,589Zhongwu Guo · University Of Florida · R01 · FY2016 · CA